Nemera announces the launch of DuoSpray in September 2026, a bidose nasal spray platform designed to support nasal drug-device combination product development for systemic drug administration.
The nasal route represents a non-invasive, needle-free administration alternative for systemic therapies, offering rapid onset of action and enabling self-administration without healthcare professional intervention.
